BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21945434)

  • 41. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein.
    Orr AA; Wördehoff MM; Hoyer W; Tamamis P
    J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease.
    Lu JX; Dong XQ; Zhang JJ
    Protein Pept Lett; 2017; 24(4):322-330. PubMed ID: 28183246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
    Necula M; Kayed R; Milton S; Glabe CG
    J Biol Chem; 2007 Apr; 282(14):10311-24. PubMed ID: 17284452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Cationic Gallium Phthalocyanine Inhibits Amyloid β Peptide Fibril Formation.
    Tabassum S; Sheikh AM; Yano S; Ikeue T; Mitaki S; Michikawa M; Nagai A
    Curr Alzheimer Res; 2020; 17(7):589-600. PubMed ID: 33032510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
    Olofsson A; Lindhagen-Persson M; Sauer-Eriksson AE; Ohman A
    Biochem J; 2007 May; 404(1):63-70. PubMed ID: 17280549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q; Yu X; Li L; Zheng J
    Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A long-lived Aβ oligomer resistant to fibrillization.
    Nick M; Wu Y; Schmidt NW; Prusiner SB; Stöhr J; DeGrado WF
    Biopolymers; 2018 Aug; 109(8):e23096. PubMed ID: 29319162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
    Loureiro JA; Rocha S; Pereira Mdo C
    J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid Conversion of Amyloid-Beta 1-40 Oligomers to Mature Fibrils through a Self-Catalytic Bimolecular Process.
    Morel B; Carrasco-Jiménez MP; Jurado S; Conejero-Lara F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seeding specificity in amyloid growth induced by heterologous fibrils.
    O'Nuallain B; Williams AD; Westermark P; Wetzel R
    J Biol Chem; 2004 Apr; 279(17):17490-9. PubMed ID: 14752113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ.
    Garai K; Frieden C
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3321-6. PubMed ID: 23401512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulating Aβ Fibrillogenesis with 'Trojan' peptides.
    Pandey G; Morla S; Kumar S; Ramakrishnan V
    Neuropeptides; 2020 Jun; 81():102030. PubMed ID: 32156470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.
    Hu Y; Zheng H; Su B; Hernandez M; Kim JR
    Biochim Biophys Acta; 2012 Oct; 1824(10):1069-79. PubMed ID: 22709576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.
    Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A
    FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The protective effects of crocetin on aβ₁₋₄₂-induced toxicity in Ht22 cells.
    Kong Y; Kong LP; Luo T; Li GW; Jiang W; Li S; Zhou Y; Wang HQ
    CNS Neurol Disord Drug Targets; 2014; 13(9):1627-32. PubMed ID: 25106634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBK
    Kravenska Y; Nieznanska H; Nieznanski K; Lukyanetz E; Szewczyk A; Koprowski P
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183337. PubMed ID: 32380169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.